Jeremiah W Sanders1, Jason M Johnson2, Henry Szu-Meng Chen1, Melissa Chen2, Maria Gule-Monroe2, Zijian Zhou1, Tina M Briere3, Jing Li4, Jingfei Ma1, and Ho-Ling Liu1
1Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX, United States, 2Neuroradiology, University of Texas MD Anderson Cancer Center, Houston, TX, United States, 3Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, United States, 4Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States
Synopsis
Metastasis is regarded as a highly inefficient process in that less than
0.01% of circulating tumor cells eventually succeeds in forming secondary tumor
growths. The seed and soil theory suggests that certain
tumor cells have a specific affinity for the milieu of certain organs. Numerous studies have attempted to better understand the biology behind
the distribution of brain metastasis and theories include both variables
involving the metastasis and the target brain parenchyma. This
work establishes probabilistic maps of locations where 13 primary cancer subtypes metastasize to the brain from T1-weighted MRIs of 955 patients undergoing stereotactic radiosurgery.
Introduction
Metastasis is regarded as a highly inefficient process in that less than
0.01% of circulating tumor cells eventually succeeds in forming secondary tumor
growths [1]. Over a century ago, Paget studied whether the
distribution of metastases was due to chance. His analysis of over 1000
autopsy records of women with breast cancer suggested a pattern of
metastasis that was not random. This suggested that
certain tumor cells have a specific affinity for the milieu of certain organs
(seed and soil theory) [2]. Since that time numerous studies have attempted to
better understand the biology behind the distribution of brain metastasis and
theories include both variables involving the metastasis and the target brain
parenchyma. The purpose of this work was to create probabilistic maps of
locations where primary cancers metastasize to the brain from a large database
of contrast-enhanced T1w brain MRIs across a range of cancer subtypes.Methods
This
retrospective study was performed under a HIPPA compliant and IRB approved
protocol. Informed patient consent was waived. 955 patients undergoing gamma
knife radiosurgery were included in this study. Each patient was scanned with a
3D post-contrast T1-weighted spoiled gradient recalled echo MR sequence.
Typical scan parameters were: TR/TE = 6.9/2.6 ms, NEX = 2, flip angle = 12°,
matrix size = 256×256, FOV = 24×24 cm, voxel size = 0.94×0.94×1.00 mm. A total
of 3978 brain metastases were identified by three board-certified neuroradiologists
and contoured by the treating board-certified radiation oncologists. The patient
records and radiology reports were used to code the primary cancer subtypes into
13 sub-categories by a board-certified neuroradiologist (7 years of experience) (Figure 1).
The
MRIs and metastasis segmentation masks were converted from DICOM to NIFTI
format for neuroimage analysis. The MRIs and corresponding metastasis
segmentation masks were spatially normalized into standard MNI space (Montreal
Neurological Institute, MNI152 atlas) at 1.0 mm isotropic resolution using
SPM12 (Wellcome Department of Cognitive Neurology, Institute of Neurology,
London, UK) and its default normalization and parameters. The registered
segmentation masks were grouped by the corresponding primary cancer subtype.
The segmentation masks were superimposed to create probability maps of
voxel-wise metastasis location frequency (normalized by the number of metastases used to create each probability map). Heat maps were constructed and
overlaid on a representative T1w brain image for anatomical visualization and
comparison.
Clusters
of metastases were identified by finding overlapping voxel regions on the
probability maps. The anatomic brain regions of the clusters were identified
from the superimposed heat map and MRI. Differences in metastases location were
identified, and the probability of metastases locations were computed for
different brain regions across the 13 primary cancer subtypes.Results
The average metastasis volume was 900.2 ± 2238.3 mm3
(skewness = 4.7). Each patient had an average of 4.2 ± 3.4 metastases (skewness
= 2.1) (Figure 1). Although many metastases locations appeared to be random,
the probability map containing metastases locations from all 13 cancer subtypes
combined showed brain regions with distinct clustering in the cerebellum, right
occipital lobe, and left and right areas of the frontal lobe (Figure 2).
Subgroups analysis of metastasis distribution revealed differences between
non-small-cell lung carcinoma (NSCLC) (cerebellum and convexity predominance) (Figure 3), melanoma (random distribution) (Figure 4), and breast cancer
(cerebellum and occipital lobe predominance) (Figure 5). Other metastatic groups were not
as rigorously analyzed due to their smaller sample sizes.Discussion and conclusion
Prior
investigations into the distribution of brain metastases were limited due to
sample size and time intensive localization methodology. We have successfully
demonstrated the ability to visualize the spatial distribution of a large
number of metastatic brain lesions (3978 total metastases) in nearly a thousand
patients with division by cancer type. Differential regions of clustering were
identified for the three major cancer subtypes (NSCLC, melanoma, and breast).
Regions of clustering, as well as regions absent of clustering, are of interest
in refining the “seed and soil” theory in large datasets and provides the
opportunity to further investigate novel hypotheses such as molecular cancer
subtype (for example, ER/PR/Her2Neu status), gender, and chemotherapy type.Acknowledgements
No acknowledgement found.References
[1] Fidler IJ. “Metastasis:
quantitative analysis of distribution and fate of tumor emboli labeled with
125I-5-iodo-2′-deoxyuridine,” Journal of
the National Cancer Institute, 1970: 45(4); 773-782.
[2] Paget S. “The distribution of
secondary growths in cancer of the breast,” Lancet,
1889: 1; 571-573.